Universal Vision Biotechnology Co., Ltd. (TPEX:3218)
Taiwan · Delayed Price · Currency is TWD 143.00
+0.50 (0.35%)
Oct 31, 2025, 2:31 PM CST
TPEX:3218 Market Cap
TPEX:3218 has a market cap or net worth of 12.12 billion as of October 31, 2025. Its market cap has decreased by -41.63% in one year.
Market Cap
12.12B
Enterprise Value
11.74B
Revenue
4.26B
Ranking
n/a
PE Ratio
13.69
Stock Price
143.00
Market Cap Chart
Since November 3, 2008, TPEX:3218's market cap has increased from 1.01B to 12.12B, an increase of 1,105.03%. That is a compound annual growth rate of 15.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 12.12B | -28.50% |
| Dec 31, 2024 | 16.94B | -27.80% |
| Dec 29, 2023 | 23.47B | -1.63% |
| Dec 30, 2022 | 23.86B | 10.75% |
| Dec 30, 2021 | 21.54B | 18.41% |
| Dec 31, 2020 | 18.19B | 254.07% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 233.43B |
| PharmaEssentia | 184.18B |
| Lotus Pharmaceutical | 77.71B |
| Bora Pharmaceuticals Co., LTD. | 77.08B |
| Lumosa Therapeutics | 35.38B |
| Oneness Biotech | 30.99B |
| Pegavision | 26.56B |
| Polaris Group | 26.43B |